ISTH 2021 Congress

Venous Thromboembolism » Atrial Fibrillation

Theme Navigation

ISTH 2021 Congress
- Venous Thromboembolism
  - Atrial Fibrillation

Abstract Number: PB1072

A Comparative Cohort Study of Serum Rivaroxaban Levels in Singaporean (SG) and British (UK) Non-valvular Atrial Fibrillation (NVAF) Patients

E.X. Yong¹, Y.Y. Lin², D. Tan¹, E. Chan¹, V. Speed³, J. Patel³, E.S. Yap⁴, G. Chang², P. Gallagher¹

Abstract Number: PB1073

A Comparison of the Incidence of Traumatic Brain Injury in Anticoagulated and Non-anticoagulated Head Injured Patients

F. Al-Haimus¹, N. Clayton^1,2, J. Klyn², K. de Wit^3,1

Abstract Number: PB1081

Accounting of Symptoms and Ejection Fraction May Improve Prediction of Left Atrial Thrombus in Patients with Non-valvular Atrial Fibrillation before Catheter Ablation or Cardioversion

I. Zaigraev¹, I. Yavelov¹, O. Drapkina¹, E. Bazaeva¹

Abstract Number: PB1075

Appropriate dose of Dabigatran in Asian Population

N. Hantrakun¹, W. Wongcharoen¹, K. Thiankhaw¹, L. Norasetthada¹, A. Tantiworawit¹, E. Rattaritamrong¹, T. Rattanathammethee¹, S. Huntrakool¹, P. Piriyakhuntorn¹, C. Chai-Adisaksopha¹

Abstract Number: PB1069

Association of Retest Interval with INR Control in Warfarin Patients with Markedly Out of Range INRs

B. Haymart¹, X. Kong¹, G.D Barnes¹, A. Purohit¹, M. Ali², E. Kline-Rogers¹, J.H Kozlowski³, G. Krol⁴, V. Shah⁴, J.B Froehlich¹, S. Kaatz⁴

Abstract Number: PB1076

Burden and Costs of Stroke/Systemic Embolism and Major Bleeding among Elderly Non-valvular Atrial Fibrillation Patients Prescribed Oral Anticoagulants

A. Dhamane¹, A. Keshishian², M. Preib², T. Bello², C. Russ³, M. Di Fusco³, M. Ferri¹

Abstract Number: PB1083

Comparative Effectiveness of Alternative Bridging Therapies for Subtherapeutic INR in Patients with Left Ventricular Assist Devices

G. Chung¹, E. Salem², E. Sippola³, S. Shore³, L. Baumann Kreuziger², G. Barnes³

Abstract Number: PB1079

Effectiveness and Safety of Direct Oral Anticoagulants in Thai Patients with Atrial Fibrillation

S. Srikajornlarp¹, K. Boonyawat¹, P. Angchaisuksiri¹, K. Likittanasombat¹, M. Amnueypol¹, P. Numthavaj¹, P. Vathesatogkit¹

Abstract Number: PB1074

Efficacy and Safety of Direct Oral Anticoagulants in Patients of Southern Italy with Atrial Fibrillation: Real-world Data from the EGINA Registry

N. Ciavarella¹, A. Ciampa², S. Bradamante³, A. Colucci⁴, G. Dirienzo⁵, A.M. Iannone⁶, G. Polimeno⁷, G. Rescigno⁸, L. Ria⁹, R. Scarafile¹⁰, A. Ciavarella¹¹, C. Custodero¹², C. Sabbà¹²

Abstract Number: PB1071

Evaluation of the Effect of Educational Intervention Adapted for Patients on Warfarin with Poor Anticoagulation Control: A Controlled Clinical Trial

J.M. Costa¹, M.S. Marcolino², M.F.S. Praxedes³, H.C. Torres⁴, R.P. Souza⁵, D.V. Nascimento¹, C.B. Ferreira¹, N.S. Antunes⁶, R.C. Viana¹, J.A. Araújo¹, L.A. Fernandes¹, L.d.F.M. Braga¹, A.C.R. Silva¹, H.C. Barbosa², D.D. Ribeiro⁶, M.A.P. Martins^1,2,6,7

Abstract Number: PB1082

Inappropriate Direct Oral Anticoagulant Dosing in a Spanish Cohort with Atrial Fibrillation

B. Navarro Almenzar¹, J.J. Cerezo Manchado², F. García Candel³

Abstract Number: PB1086

Prescribing Patterns, Efficacy and Safety of Direct Oral Anticoagulants (DOAC) Usage in a Tertiary Hospital

K.Y. Yong¹, S. Leow², E.S. Yap¹, P.S. Ong², S.C. Tan¹, P.W. Goh¹

Abstract Number: PB1084

Procedural Success of Left Atrial Appendage Occlusion Device in Patients with Chronic Kidney Disease: Meta-analysis of Real-world Data

A. Singh¹, S. Hussain², B. Antony¹

Abstract Number: PB1077